INTRODUCTION
The liver, an important metabolic organ, plays a key role in many physiological processes, including clearance of drugs and toxins, protein synthesis, and nutrient metabolism [1, 2] . Liver injury is a common consequence of various diseases, and acute hepatic failure is known to affect human health worldwide [3] . Liver injury caused by toxin-induced metabolic dysfunction often leads to inflammation, or even hepatic fibrosis [4] . Carbon tetrachloride (CCl 4 ), a potent chemical hepatotoxin, has been widely used in animal models of liver injury accompanied by inflammation and fibrosis. The metabolism of CCL 4 can yield reactive free radicals which increase lipid peroxidation and protein oxidation, leading to liver injury [5] .
The ginsenosides Rg1 and Rb1, two primary active compounds from Panax ginseng C. A. Mey,  have  been  reported  to  elicit  pharmacological  effects,  such  as  immunoregulation, neuroprotection, and hepatoprotection [6, 7] . Many studies have demonstrated that ginsenosides can function as hepatoprotective agents in multiple models of hepatic injury and other diseases [6, 7] . However, the protective mechanism of Rg1 and Rb1 in CCl 4 -induced liver injury is still unclear. In this study, the effects of Rg1 and Rb1 in a model of CCl 4 -induced acute liver injury was explored, noting changes in tissue histology and cytokine levels. The hepatoprotective mechanism of Rg1 and Rb1 was investigated in detail.
EXPERIMENTAL Materials
Ginsenosides Rg1 and Rb1 were purchased from Sigma-Aldrich (St Louis, MO, USA). The enzymatic kits for alanine aminotransferase (ALT) and aspartate transaminase (AST) were purchased from Nanjing Jiancheng Bioengineering Research Institute (Nanjing, China). All primary antibodies were purchased from Cell Signaling Technology, Inc. (Beverly, MA). All primers were purchased from Shanghai Sangon Biological Engineering Co., Ltd. (Shanghai, China). TNF-α and IL-6 ELISA kits were purchased from R&D Systems Inc. (Minneapolis, MN, USA).
Liver injury model
Male ICR mice, purchased from Vital River Laboratory Animal Technology Co., Ltd. (Beijing, China), were housed at 23 °C, given free access to food and water. All animal experiments were performed in accordance with Guide for the Care and Use of Laboratory Animals [8] and approved by the animal ethics committee of Wuhan Third Hospital (approval no. KY2018-026). Acute liver injury was induced by CCl 4 . Thirty-two mice were randomly divided into four groups (control, CCl 4 , Rg1, and Rb1). Control mice were administered sodium carboxymethylcellulose (CMC-Na, 0.5 %, the same volume used for the Rg1 and Rb1 groups) by intraperitoneal injection for seven days. CCl 4 -treated mice were treated like the controls for the first seven days and then intraperitoneally injected with CCl 4 [10 mg/kg (v/v) in 0.3 % olive oil] on day 8. Rb1-and Rg1-treated mice were intraperitoneally injected with Rb1 and Rg1 (each 30 mg/kg, dissolved in 0.5% CMC-Na), for seven days and then intraperitoneally injected with CCl 4 [10 mg/kg (v/v) in 0.3 % olive oil] on day 8. After 24 h, all mice were sacrificed by cervical vertebra disjointing, liver and blood samples were collected for further analysis.
Haematoxylin and eosin (H&E) staining of mouse liver
The left lobes of mouse liver were washed with phosphate buffer saline then were fixed in formalin (0.4 %) for haematoxylin and eosin (H&E) staining. After dehydration in graded alcohol, the tissue was embedded in paraffin and cut into 3 to 4 µm sections on a Leica SM2010 R Sliding Microtome (Leica, Buffalo Grove, IL, USA). The sections were then deparaffinized, rehydrated, and stained with hematoxylin-eosin for 5 min at 37 °C. Finally, the sections were mounted in neutral Canada balsam after dehydration, observed by optical microscopy, and evaluated by pathologists, blind to the identity of the sections.
Analysis of serum ALT and AST levels
Blood was centrifuged at 3000 rpm/min for 5 min, and the serum was analyzed for ALT (C009-2) and AST (C010-2) levels using commercial ELISA kits according to the manufacturer's protocol.
Determination of liver TNF-α and IL 6 levels
Mouse livers were rinsed in saline. One lobe of the liver was rinsed in saline [1:9 (m/v)], and homogenized in ice-cold Nonidet P 40 (NP-40) using a glass homogenizer. TNF-α and IL 6 levels in liver homogenates were measured by ELISA, according to the manufacturer's instructions.
Western blotting
Liver tissues were homogenized in RIPA buffer, and proteins were quantified using the BCA method (Thermo Scientific, Rockford, IL, USA). Equal amounts of protein were loaded and separated on a 10 % SDS-polyacrylamide gel and transferred onto a PVDF membrane (Millipore, MA). After blocking, the membranes were incubated with respective primary antibodies [TGFβ (#79424), Smad2 (#5339), and Smad3 (#9523) at a 1:1,000 dilution] and secondary antibodies (1:10,000 dilution). The proteins were detected by chemiluminescence and quantified using ImageJ software.
Real-time reverse transcription-polymerase chain reaction (RT-PCR)
Total liver RNA was extracted using TRIzol reagent (Invitrogen) and reverse-transcribed into cDNA using the GoScript™ Reverse Transcription System (Promega). Quantitative RT-PCR was performed using the SYBR Green PCR Master Mix reagent kit (Promega). The primers used for RT-PCR were described previously [9] .
Statistical analysis
Statistical analysis was performed using one-way ANOVA or Tukey's test by SPSS software (Chicago, IL, USA) Data are presented as mean ± standard deviation (SD), with p < 0.05 was considered statistically significant.
RESULTS

Histopathological features
Histological changes in the liver were observed by H&E staining. As shown in Figure 1 , Liver from control mice ( Figure 1A ) had clear lobules and regular cord structures, whereas livers from CCl 4 -treated mice showed apparent pathological changes, including vacuoles (arrows) and necrosis, indicative of severe liver damage ( Figure 1B) . Pre-treatment with Rg1 ( Figure 1C ) or Rb1 ( Figure 1D ) attenuated the severity of liver injury, with a corresponding decrease in the number of vacuoles with no apparent necrosis. 
Effects of Rg1 and Rb1 on ALT and AST levels
As shown in Figure 2 , ALT levels in the CCl 4 group were about 2.5 times higher than in the control group, and AST levels were present at five-fold higher levels than in the control group. ALT and AST levels in Rg1-or Rb1-treated mice decreased significantly when compared with the CCl 4 group. These results are in accordance with the histopathological results. 
Effects of Rg1 and Rb1 on liver cytokine expression levels
Proinflammatory cytokines, such as IL-6 and IL-8, are crucial mediators contributing to the development of liver inflammation. The effects of Rg1 and Rb1 on IL-6 and IL-8 levels in CCl 4 -treated mice were investigated, and the results are shown in Figure 3 . IL-6 levels in the CCl 4 group was about three-fold higher than in the control group, and IL-8 levels were five-fold higher than in the control group. IL-6 and IL-8 levels decreased significantly after Rg1 and Rb1 pre-treatment when compared with the CCl 4 group, which indicate that Rg1 and Rb1 attenuate inflammation induced by liver damage. Effects of Rg1 and Rb1 on the TGF-β/Smad signalling pathway As shown in Figure 4 , TGF-β, Smad2, and Smad3 levels were increased in CCl 4 group compared with control group. Pre-treatment with Rg1 or Rb1 blocked the high expression of TGF-β, Smad2, and Smad3 induced by CCl 4 , which indicates that Rb1 and Rg1 can attenuate liver injury induced by CCl 4 by regulating the TGF-β/Smad signalling pathway. 
DISCUSSION
The liver is an important metabolic organ. Liver injury causes inflammation, which can contribute to various pathological events [10] . As a wellknown hepatotoxin that gives rise to free radicals, CCl 4 is widely used in liver injury models. Trichloromethyl radical, the metabolite of CCl 4 , causes lipid peroxidation which can activate Küpffer cells and trigger the production of inflammatory cytokines [11, 12] . CCl 4 -induced liver injury is believed to mimic the liver damage caused by various toxins in humans [13] .
Inflammation and oxidative stress are closely related to liver injury and fibrosis. Many studies have demonstrated that anti-inflammatory and oxidative agents such as epigallocatechin-3-gallate, are able to significantly attenuate the severity of CCl 4 -induced liver injury and fibrosis [14] . A previous study demonstrated that ginseng essence extracted from four medicinal, edible herbs (P. ginseng, Panax quinquefolius, Nelumbo nucifera, and Lilium longiflorum), can attenuate CCl 4 -induced liver inflammation and fibrosis by inhibiting oxidative stress [15] . The two compounds in this study, Rg1 and Rb1, are the two primary active compounds in P. ginseng C. A. Mey. The current study showed that Rg1 and Rb1 attenuated the severity of CCl 4 -induced liver injury and regulate inflammation and fibrosis.
TGF-β, the main fibrogenic cytokine produced by Küpffer and stellate cells in the liver, was overexpressed in CCl 4 -induced liver injury in mice. Activation of the TGF receptor leads to the phosphorylation of Smad2 and Smad3 [16, 17] .
Results of previous studies found that blocking TGF-β signalling significantly protect rats from toxin-induced liver fibrosis [18, 19] . The results of this study indicate that Rg1 and Rb1 inhibit the TGF-β/Smad signalling pathway and attenuate liver injury and fibrosis. Moreover, In addition, further studies about the precise mechanism of the association between inflammation and fibrosis are also needed. Such research will allow a better understanding of the hepatoprotective effects of ginsenosides and provide guidance for their clinical use.
CONCLUSION
The results of this study indicate that Rg1 and Rb1 attenuate CCl 4 -induced liver injury and inflammation by regulating TGF-β/Smad signalling pathway, suggesting the potential value of ginsenosides in clinical management of liver inflammation.
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